2,600 results match your criteria: "Late Effects of Childhood Cancer and Treatment"
Cancer Med
November 2024
Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
Oral Oncol
December 2024
Department of Pediatric Dentistry, Indiana University School of Dentistry, and James Whitcomb Riley Hospital for Children, Indianapolis, IN, USA. Electronic address:
Background: The purpose of the present systematic review and meta-analyses was to appraise the case-control studies that have evaluated late adverse effects of chemotherapy for treating hematological malignancies in pediatric patients.
Methods: Five electronic databases along with grey literature were searched using broad keywords and MeSH terms for the articles that could meet the eligibility criteria. The Newcastle-Ottawa Scale was employed for quality assessment.
Pediatr Blood Cancer
November 2024
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Background: Childhood cancer survivors (CCS) are at risk for medical and psychosocial late effects of their disease and its treatment and are recommended to receive annual follow-ups. Yet, rates of follow-up adherence are suboptimal and may be influenced by the organization and delivery of their healthcare. This research aimed to examine experts' perceptions of facilitators and barriers to healthcare organization and delivery to CCS.
View Article and Find Full Text PDFCancer Epidemiol
December 2024
INSERM, U900, Institut Curie, PSL Research University, Saint-Cloud, France; Conservatoire National des Arts et Métiers, Paris, France.
J Cardiovasc Med (Hagerstown)
January 2025
Division of Cardiology, University Hospital 'Paolo Giaccone'.
Turk J Haematol
November 2024
Division of Pediatric Hematology and Bone Marrow Transplantation Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
J Adolesc Young Adult Oncol
November 2024
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Childhood cancer survivors' (CCS) knowledge about late effects can promote positive health behaviors and autonomy. Cardiotoxicity is a major source of morbidity, which can be mitigated through exercise. Descriptive and Fisher's exact statistics were used to characterize health knowledge and physical activity in CCS ≥13 years at high risk for cardiotoxicity.
View Article and Find Full Text PDFBMC Pediatr
October 2024
Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA, US.
Acta Haematol
October 2024
University Leipzig Medical Center, Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany.
Cancer Med
October 2024
Departments of Hematology and IQ Health, Radboud University Medical Centre, Nijmegen, The Netherlands.
Background: Childhood cancer survivors face high risks of adverse late health effects. Long-term follow-up care for childhood cancer survivors is crucial to improve their health and quality of life. However, implementation remains a challenge.
View Article and Find Full Text PDFInt J Cancer
October 2024
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Acute lymphoblastic leukemia (ALL) constitutes approximately 25% of pediatric cancers, and with contemporary protocols, the 5-year survival rate is over 90%. Despite improved survival, neurocognitive impairments from treatment raise concerns. This registry study aimed to explore the impact of ALL treatment on educational outcomes from school year nine in Swedish children.
View Article and Find Full Text PDFJAMA Netw Open
October 2024
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Importance: Childhood cancer survivorship programs and long-term follow-up (LTFU) practices are inadequate in most regions of China.
Objective: To understand the clinician and caregiver perceptions of LTFU care and to identify barriers to adherence to LTFU care in mainland China.
Design, Setting, And Participants: This survey study had a 2-phase sequential mixed-methods approach, consisting of a cross-sectional survey followed by semistructured interviews.
Appl Neuropsychol Child
October 2024
Clinical Health Psychology, Great North Children's Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Childs Nerv Syst
October 2024
Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS, Utrecht, Netherlands.
Background: Low-grade glioma is the most common brain tumor in children with different modes of treatment and a high overall survival. Low-grade glioma is considered a chronic disease, since residual tumor is present in many children. The tumor and its treatment lead to acquired brain injury with diverse consequences for later life based on factors like the diverse tumor locations, treatment(s) applied, neurofibromatosis type 1, and age at diagnosis.
View Article and Find Full Text PDFPediatr Dermatol
November 2024
Department of Dermatology, West Virginia University, Morgantown, West Virginia, USA.
Pediatr Blood Cancer
December 2024
Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Ann Acad Med Singap
September 2024
General Paediatrics Service, Department of Paediatrics, KK Women's and Children's Hospital, Singapore.
Introduction: Childhood cancer survivors (CCS) are at risk of experiencing psychological distress years after completing cancer treatments. We aimed to assess the prevalence and associated risk factors affecting psychological distress and health-related quality of life (HRQOL) among CCS in Singapore, and compare with their siblings without a history of or existing cancer as control.
Method: We recruited 143 young adult CCS aged ≥18 years attending survivorship clinics at KK Women's and Children's Hospital in Singapore who were in remission for ≥5 years and treatment-free for ≥2 years, and 57 siblings.
Pediatr Blood Cancer
December 2024
Department of Pediatric Hematology/Oncology, Cancer Children's Hospital of Egypt 57357, Cairo, Egypt.
Pediatr Blood Cancer
December 2024
Departments of Pediatrics, Medicine, and Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Lifelong, guideline-based monitoring for late effects is recommended for childhood cancer survivors (CCS). We examined rates of receiving surveillance tests among at-risk young adult CCS in a population-based study (n = 253; 50% Hispanic/Latino; mean post-treatment interval 14.5 years, range: 5-22).
View Article and Find Full Text PDFJ Cancer Surviv
September 2024
Department of Physical Performance, Norwegian School of Sport Sciences, PB 4014 Ullevaal Stadion, NO-0806, Oslo, Norway.
Purpose: In childhood cancer survivors (CCS), high physical activity (PA) and low sedentary time may reduce risks of late-effects. PA behaviors and screen time, and how they relate to moderate-to-vigorous PA (MVPA) in CCS, are largely unknown. We examined PA behaviors and screen time, and their cross-sectional associations with MVPA.
View Article and Find Full Text PDFDiscov Oncol
September 2024
Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
Purpose: Childhood Cancer Survivors (CCSs) have an increased risk for treatment-related chronic health conditions, but the adherence to long-term follow-up (LTFU) care decreases over time. We therefore assessed the CCSs' development of cancer knowledge, cancer worries, self-management skills, and expectations for LTFU care in a structured, cancer center-based transition model-a crucial part for maintaining adherence.
Methods: Using questionnaire-based surveys, we compared the CCSs' cancer knowledge with medical record data and assessed cancer worries (6 questions), self-management skills (15 questions), and expectations (12 questions) longitudinally by validated scales.
Hum Reprod
November 2024
Pediatric Oncology, Cancer Center Amsterdam, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Study Question: What is the impact of the EuroNet-PHL-C2 treatment for boys with classical Hodgkin lymphoma (cHL) on semen parameters?
Summary Answer: More than half of the patients (52%, n = 16/31) had oligozoospermia or azoospermia at 2 years from cHL diagnosis; particularly boys treated for advanced-stage cHL had low sperm counts and motility.
What Is Known Already: Chemotherapy and radiotherapy to the inguinal region or testes can impair spermatogenesis and result in reduced fertility. The EuroNet-PHL-C2 trial aims to minimize radiotherapy in standard childhood cHL treatment, by intensifying chemotherapy.
J Clin Endocrinol Metab
September 2024
Endocrinology and Diabetic Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Context: In recent studies of childhood cancer survivors, diabetes has been considered a late effect associated with high therapeutic doses of radiation therapy. Our recent study of atomic bomb (A-bomb) survivors also suggested an association between radiation dose and diabetes incidence, with exposure city and age at exposure as radiation dose effect modifiers. Insulin resistance mediated by systemic inflammation and abnormal body composition has been suggested as a possible primary mechanism for the incidence of diabetes after total body irradiation, however, no studies have examined low-to- moderate radiation exposure (<4 Gy) and insulin resistance in A-bomb survivors.
View Article and Find Full Text PDF